Buying More Rocket Lab After $397 Million Update
The aerospace firm has been awarded a significant contract by the U.S. Space Force.
The $10K Portfolio: Gunnin’ for Some More Smith & Wesson
As gun ownership appears to be on the rise, I’m adding to this weapons maker. Also, I’m eyeing an exit for this stock.
Sticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward
The small-cap healthcare firm offered some encouraging earnings results.
Adding to a Couple of Troubled Positions as July Comes to a Close
Here’s our trading plan for Friday and the upcoming earnings calendar for portfolio names.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.
5 Stocks We Want to Buy on Weakness Ahead of Earnings
Here’s our shopping list for Friday as well as the latest portfolio news.
Our Small-Cap Defense Name Surges After $70 Million Update
Plus, SoFi is set to release some important earnings data.
Buying More of This Small-Cap Name as Shares Fall Under Pressure
We’re also looking to take some profit after a $6.9 million update boosted another name.
Why I’m Not Chasing AMC’s Odyssey
Here’s the latest on our Ocular Therapeutix trading strategy, a planned purchase for today and some additional portfolio news.
Our Ocular Call Is Set to Expire as Market Struggles
We’re a bit handcuffed when it comes to making moves in our small-cap portfolio.